| Literature DB >> 34991556 |
Jenna R Adalbert1,2, Asif M Ilyas3,4.
Abstract
BACKGROUND: The United States opioid epidemic is a devastating public health crisis fueled in part by physician prescribing. While the next generation of prescribers is crucial to the trajectory of the epidemic, medical school curricula designated to prepare students for opioid prescribing (OP) and pain management is often underdeveloped. In response to this deficit, we aimed to investigate the impact of an online opioid and pain management (OPM) educational intervention on fourth-year medical student knowledge, attitudes, and perceived competence.Entities:
Keywords: Medical education; Opioid epidemic; Opioid prescribing; Pain management; Virtual curriculum
Mesh:
Substances:
Year: 2022 PMID: 34991556 PMCID: PMC8733773 DOI: 10.1186/s12909-021-03058-z
Source DB: PubMed Journal: BMC Med Educ ISSN: 1472-6920 Impact factor: 2.463
Fig. 1Examples of slides from Case #3 including the learning objectives and case introduction
Fig. 2Examples of slides from Case #3 including an interactive multiple-choice question and case progression with illustration
Fig. 3Examples of two “Prescriber Practice” case vignettes included at the end of each patient case
Pre- and posttest ranks of medical student median scores for each question and overall using the Wilcoxon matched-pairs signed-rank test
| Module Pre- & Posttest Ranks | |||
|---|---|---|---|
| Median (Interquartile Range) | |||
| Question | Pretest | Posttest | |
| How satisfied are you with the amount of OP training that you have received in your formal education thus far? | 3 (2) | 4 (1) | < 0.001 |
| I understand the risks of opioids in chronic PM. | 4 (0) | 4 (1) | < 0.002 |
| I understand the benefits of opioids in chronic PM. | 4 (0) | 4 (1) | < 0.001 |
| I understand when it is appropriate to prescribe opioids for chronic PM. | 3 (1) | 4 (1) | < 0.001 |
| I understand the risks of opioids in acute PM. | 4 (0) | 5 (1) | < 0.001 |
| I understand the benefits of opioids in acute PM. | 4 (0) | 5 (1) | < 0.001 |
| I understand when it is appropriate to prescribe opioids for acute PM. | 3 (2) | 4 (1) | < 0.001 |
| I am familiar with the types of opioid medications used for PM. | 4 (1) | 4 (1) | < 0.001 |
| I am familiar with the types of non-opioid medications used for PM. | 4 (0) | 5 (1) | < 0.001 |
| I understand the role of prescription opioids in the opioid epidemic. | 4 (1) | 5 (1) | < 0.001 |
| I am familiar with the Prescription Drug Monitoring Program and know when to use it. | 4 (1) | 5 (1) | < 0.001 |
| I am familiar with OP guidelines (i.e. dosages and amounts to prescribe). | 2 (1) | 4 (0) | < 0.001 |
| I understand the differences in OP for older adults (> 65) vs. adults (< 65). | 2 (1) | 4 (1) | < 0.001 |
| I understand the complexities of pain assessment in patients with dementia. | 3 (2) | 4 (1) | < 0.001 |
| I understand the differences between nociceptive, neuropathic and inflammatory pain. | 4 (1) | 5 (1) | < 0.001 |
| I am familiar with the risks and benefits of commonly used pain medications for older adults (> 65). | 3 (2) | 5 (1) | < 0.001 |
| I am familiar with safe PM strategies for older adults (> 65). | 3 (2) | 4 (1) | < 0.001 |
| I understand the differences in treating nociceptive, neuropathic and inflammatory pain. | 3 (2) | 5 (1) | < 0.001 |
| I am familiar with first-line treatments and strategies for chronic PM. | 3 (2) | 5 (1) | < 0.001 |
| I understand the concept of “opioid diversion.” | 3 (2) | 5 (1) | < 0.001 |
| I am familiar with safe strategies for disposing of unused opioids. | 2 (2) | 5 (1) | < 0.001 |
| I am familiar with the risk factors for patient opioid misuse. | 4 (1) | 5 (1) | < 0.001 |
| I am familiar with safe management strategies for patients on long-term opioid treatment for chronic pain. | 2 (1) | 4 (1) | < 0.001 |
| I understand the concept of opioid tapering. | 4 (1) | 4 (1) | < 0.001 |
| I understand the concept of morphine milligram equivalents (MMEs). | 4 (2) | 5 (1) | < 0.001 |
| I understand how to convert morphine milligram equivalents (MMEs). | 2 (3) | 5 (1) | < 0.001 |
| I am familiar with the symptoms of an opioid overdose. | 4 (1) | 5 (1) | < 0.005 |
| I understand the role of naloxone in opioid overdose. | 5 (1) | 5 (0) | < 0.002 |
| I understand the importance of co-prescribing naloxone with opioids. | 4 (1) | 5 (0) | < 0.001 |
| I understand the role of medication-assisted treatment (MAT) in patients with OUD. | 4 (1) | 5 (0) | < 0.001 |
| I understand the differences between methadone, buprenorphine, and naltrexone. | 4 (1) | 5 (1) | < 0.001 |
| I understand the concept of patient-controlled analgesia (PCA). | 4 (0) | 5 (1) | < 0.001 |
| I am familiar with the differences in opioid dosing requirements for opioid-tolerant vs. opioid-naive patients. | 3 (2) | 4 (1) | < 0.001 |
| I understand the danger of co-prescribing benzodiazepines and opioids. | 4 (1) | 5 (0) | < 0.001 |
| I understand the role of multimodal analgesia in PM. | 4 (0) | 5 (1) | < 0.001 |
| I understand the differences in pain medication dosing for the pediatric vs. adult population. | 2 (1) | 4 (1) | < 0.001 |
| I am familiar with the risks of prescribing opioids to adolescents for PM. | 4 (2) | 4 (1) | < 0.001 |
| I am familiar with pain medications that are safe for pregnant patients. | 2 (2) | 4 (2) | < 0.001 |
| I am familiar with safe opioid management strategies for pregnant patients. | 2 (1) | 4 (1) | < 0.001 |
| I understand the postnatal effects of opioids on neonates. | 4 (0) | 5 (1) | < 0.001 |
| I am familiar with the concept of pain syndromes in cancer survivors. | 3 (2) | 4 (1) | < 0.001 |
| I understand the role of opioids in chronic cancer pain. | 4 (1) | 4 (1) | < 0.001 |
| I am confident in my ability to manage opioids for patient pain. | 2 (1) | 4 (0) | < 0.001 |
| I am capable of managing opioids for patient pain. | 2 (1) | 4 (0) | < 0.001 |
| I am able to provide opioid management for patient pain. | 2 (2) | 4 (0) | < 0.001 |
| I am able to meet the challenge of opioid management for patient pain. | 3 (2) | 4 (0) | < 0.001 |
| 150 (24) | 206 (25) | < 0.001 | |
Fig. 4General performance distribution of overall student pre- and posttest scores
Fig. 5Pre- and posttest changes on a 5-level Likert scale of median medical student perceived competence scores